The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
Z

Imatinib for CML: Can We Achieve CCyR in All Stages? Can We Prolong EFS With Imatinib Mesylate in Chronic Phase? Does QoL Improve After 1L Treatment? Experience from a Developing Country

By The Asian Oncology Society 1st Virtual International Conference FEATURING Zeba Aziz
By The Asian Oncology Society 1st Virtual International Conference FEATURING Zeba Aziz
0 views
February 25, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
Hematologic Oncology
15:18
The Asian Oncology Society 1st Virtual International Conference

Whole Course Management of Chemo-Induced Thrombocytopenia: How Do We…

Feat. Z. Lingyun
17:53
The Asian Oncology Society 1st Virtual International Conference

Imatinib for CML: Can We Achieve CCyR in All Stages? Can We Prolong …

Feat. Z. Aziz